Skip to main content

Kintegral Advisory, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1569518 New York, NY

Position in REGN

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$695,870
-$166,396 QoQ
Shares Held
1,116
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#726
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Kintegral Advisory, LLC holds $3,873,451 across 2 Biotechnology names. REGN ranks #2 (18.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
1,116 $695,870

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $695,870 1,116
2026-03-31 $862,266 1,116
2025-12-31 $900,000 1,166
2025-09-30 $673,599 1,198
2025-06-30 $631,575 1,203
2025-03-31 $764,881 1,206
2024-12-31 $861,919 1,210
2024-09-30 $1,331,921 1,267
2024-06-30 $1,348,471 1,283
2024-03-31 $656,418 682
2023-12-31 $600,750 684
2023-09-30 $566,196 688
2023-06-30 $494,355 688
2023-03-31 $565,308 688
2022-12-31 $523,080 725
2022-09-30 $664,070 964
2022-06-30 $569,849 964
2022-03-31 $658,610 943
2021-12-31 $582,261 922
2021-09-30 $557,975 922
2021-06-30 $514,973 922
2021-03-31 $436,235 922
2020-12-31 $445,427 922
2020-09-30 $516,117 922
2020-06-30 $593,714 952
2020-03-31 $464,852 952